Skip to content
Search AI Powered

Latest Stories

Professor Tony Avery OBE awarded RPS Honorary Fellowship

 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.


Professor Avery is a practicing GP, Professor of Primary Health Care at the University of Nottingham, National Clinical Director for Prescribing at NHS England, a Senior Investigator at the National Institute for Health and Care Research (NIHR), and a research co-lead at the NIHR Greater Manchester Patient Safety Research Collaboration.

Throughout his career, Professor Avery has championed the safe, effective, and appropriate use of medicines.

He has collaborated with healthcare professionals and patients to advance research and policy development in prescribing and patient safety, and led major studies on the frequency, nature, and causes of prescribing safety issues in the NHS.

Most recently, he collaborated with RPS on the development of the RPS/RCGP Repeat prescribing toolkit. He has also developed effective methods to address hazardous prescribing, including the pharmacist-led, IT-based intervention known as PINCER.

Reacting to the award, Professor Avery said: “This is a great honour to me, as I have been a strong advocate for the pharmacy profession throughout my career.”

“As a GP, I witness the excellent work of pharmacy teams on a daily basis in both community pharmacy and general practice.”

“As a researcher, my studies have demonstrated the positive impact pharmacists can make in medicines optimisation, particularly for improving medication safety.”

“In my National Clinical Director for Prescribing role, I work with fantastic pharmacy colleagues across the profession and I am in awe of their dedication and commitment to improving patient care.”

Paul Bennett, chief executive of the RPS, praised the appointment: “Professor Avery is well known for his research in primary care with a focus on patient safety, prescribing errors, medication errors, medicines optimisation and electronic prescribing systems.”

"Having collaborated closely with RPS over several years, most recently on the development of the ‘RPS/RCGP Repeat prescribing toolkit’, his significant contributions to pharmacy and RPS are fully recognised by this well-deserved award.”

“He has consistently championed the role of pharmacists as leaders in the field of research and policy development to support the safer use of medicines.

"This award reflects the high esteem in which Professor Avery and his work is held by the Society.”

Professor Avery joins a distinguished group of past recipients, including Professor Richard Parish, Dr David Taylor, Professor William Charman, Professor Sam Salek, Sir Richard Sykes Dr Stewart Adams, Prince Philip, Duke of Edinburgh (1955), who was the first recipient, and Anne, Princess Royal (2001).

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less